TGF-beta receptor mediated telomerase inhibition, telomere shortening and breast cancer cell senescence

被引:30
|
作者
Cassar, Lucy [1 ]
Nicholls, Craig [1 ]
Pinto, Alex R. [1 ]
Chen, Ruping [2 ]
Wang, Lihui [2 ]
Li, He [1 ]
Liu, Jun-Ping [1 ,2 ]
机构
[1] Monash Univ, Cent Eastern Clin Sch, Dept Immunol, Mol Signaling Lab, Prahran, Vic 3181, Australia
[2] Hangzhou Normal Univ, Sch Med, Inst Aging Res, Hangzhou 311121, Zhejiang, Peoples R China
基金
中国国家自然科学基金; 英国医学研究理事会;
关键词
BMPRII; TGFbeta; hTERT; telomerase; telomeres; senescence; breast cancer cells; BONE MORPHOGENETIC PROTEIN-7; TERT PROMOTER MUTATIONS; GROWTH-FACTOR-BETA; IN-VIVO; C-MYC; HTERT GENE; MESENCHYMAL TRANSITION; TUMOR-GROWTH; MOUSE CELLS; TRANSCRIPTION;
D O I
10.1007/s13238-016-0322-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Human telomerase reverse transcriptase (hTERT) plays a central role in telomere lengthening for continuous cell proliferation, but it remains unclear how extracellular cues regulate telomerase lengthening of telomeres. Here we report that the cytokine bone morphogenetic protein-7 (BMP7) induces the hTERT gene repression in a BMPRII receptor- and Smad3-dependent manner in human breast cancer cells. Chonic exposure of human breast cancer cells to BMP7 results in short telomeres, cell senescence and apoptosis. Mutation of the BMPRII receptor, but not TGFbRII, ACTRIIA or ACTRIIB receptor, inhibits BMP7-induced repression of the hTERT gene promoter activity, leading to increased telomerase activity, lengthened telomeres and continued cell proliferation. Expression of hTERT prevents BMP7-induced breast cancer cell senescence and apoptosis. Thus, our data suggest that BMP7 induces breast cancer cell aging by a mechanism involving BMPRII receptor- and Smad3-mediated repression of the hTERT gene.
引用
收藏
页码:39 / 54
页数:16
相关论文
共 50 条
  • [1] TGF-beta receptor mediated telomerase inhibition, telomere shortening and breast cancer cell senescence
    Lucy Cassar
    Craig Nicholls
    Alex RPinto
    Ruping Chen
    Lihui Wang
    He Li
    JunPing Liu
    Protein & Cell, 2017, 8 (01) : 39 - 55
  • [2] Telomerase inhibition, telomerase shortening, and senescence of cancer cells by tea catechins
    Naasani, I
    Seimiya, H
    Tsuruo, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 249 (02) : 391 - 396
  • [3] Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells
    Saretzki, G
    Ludwig, A
    von Zglinicki, T
    Runnebaum, IB
    CANCER GENE THERAPY, 2001, 8 (10) : 827 - 834
  • [4] Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells
    Gabriele Saretzki
    Antje Ludwig
    Thomas von Zglinicki
    Ingo B Runnebaum
    Cancer Gene Therapy, 2001, 8 : 827 - 834
  • [5] Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells
    Runnebaum, IB
    Saretzki, G
    Ludwig, A
    von Zglinicki, T
    CANCER GENE THERAPY, 2001, 8 : S2 - S2
  • [6] TGF-beta signaling in breast cancer
    Buck, Miriam B.
    Knabbe, Cornelius
    ESTROGENS AND HUMAN DISEASES, 2006, 1089 : 119 - 126
  • [7] Telomere dynamics and telomerase activity in cell senescence and cancer
    Bacchetti, S
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 1996, 7 (01) : 31 - 39
  • [8] TGF-BETA REGULATION OF CELL LOCOMOTION IS MEDIATED BY THE HYALURONAN RECEPTOR RHAMM
    GREENBERG, AH
    SAMUEL, SK
    KHALIL, N
    SAVANI, R
    YANG, BH
    TURLEY, EA
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 110 - 110
  • [9] The role of TGF-beta receptor type 3 in breast cancer progression
    Jovanovic, B.
    Ashby, W. J.
    Zijistra, A.
    Pietenpol, J. A.
    Moses, H. L.
    CANCER RESEARCH, 2012, 72
  • [10] Divergent effects of TGF-beta inhibition in bone metastases in breast and lung cancer
    Luis-Ravelo, D.
    Anton, I
    Vicent, S.
    Zandueta, C.
    Martinez, S.
    Valencia, K.
    Ormazabal, C.
    Lecanda, F.
    REVISTA DE OSTEOPOROSIS Y METABOLISMO MINERAL, 2013, 5 (02) : 79 - 84